Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.

A A Campagnari1, S M Spinola, A J Lesse

  • 1Department of Medicine, State University of New York, Buffalo 14215.

Microbial Pathogenesis
|May 1, 1990
PubMed
Summary

Conserved lipooligosaccharide (LOS) epitopes exist among diverse Gram-negative pathogens. These findings reveal shared molecular structures and varied genetic pathways for LOS assembly in bacteria like Haemophilus influenzae and Neisseria gonorrhoeae.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for Escherichia coli O157 on beef cattle ranches located near a major produce production region.

Epidemiology and infection·2014
Same author

Isolation of Campylobacter from feral swine (Sus scrofa) on the ranch associated with the 2006 Escherichia coli O157:H7 spinach outbreak investigation in California.

Zoonoses and public health·2012
Same author

Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.

Infection control and hospital epidemiology·2011
Same author

Isolation and analysis of radiolabeled meningococcal endotoxin.

Methods in molecular medicine·2011
Same author

Carbohydrate Moieties as Vaccine Candidates: meeting summary.

Vaccine·2008
Same author

Recipes for antimicrobial wine marinades against Bacillus cereus, Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella enterica.

Journal of food science·2007

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Non-enteric Gram-negative human pathogens, including *Haemophilus influenzae*, *Neisseria gonorrhoeae*, and *Moraxella catarrhalis*, share similar lipooligosaccharide (LOS) structures lacking repeating O-antigens.
  • Understanding the conservation of LOS oligosaccharide epitopes is crucial for developing broad-spectrum diagnostics and therapeutics against these pathogens.

Purpose of the Study:

  • To investigate the conservation of lipooligosaccharide (LOS) oligosaccharide epitopes among various non-enteric Gram-negative human pathogens.
  • To characterize the cross-reactivity of monoclonal antibodies (mAbs) targeting LOS epitopes across different bacterial species and genera.

Main Methods:

  • Generation and characterization of 21 monoclonal antibodies (mAbs) against *H. influenzae*, *N. gonorrhoeae*, and *N. meningitidis*.

Related Experiment Videos

  • Assessment of mAb cross-reactivity against LOS from various bacterial strains, including different genera and species.
  • Analysis of LOS band molecular weights and hybridization of a lipooligosaccharide synthesis gene fragment to bacterial DNA.
  • Main Results:

    • Five mAbs were strain-specific to non-typable *H. influenzae*.
    • Ten mAbs recognized LOS epitopes common to a genus or species, and six mAbs bound to epitopes shared across different genera.
    • Specific mAbs, like 3F11 (mimicking blood-group antigen) and 3D9 (recognizing KDO), demonstrated cross-reactivity with LOS from multiple pathogens, sometimes with varying molecular weights.

    Conclusions:

    • Conserved lipooligosaccharide (LOS) epitopes are present among diverse non-enteric Gram-negative human pathogens.
    • Different genetic mechanisms may underlie the assembly of these conserved LOS epitopes in various bacterial species.
    • These conserved epitopes represent potential targets for broader diagnostic and therapeutic strategies against related bacterial infections.